Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23541189 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Lurasidone;   Drug: Olanzapine;   Drug: Placebo comparator;   Drug: Lurasidone 40 mg tablets

Indicates status has not been verified in more than two years